Vitamin D deficiency increases the risk of developing multiple sclerosis (MS) but there is uncertainty about what dose and form of vitamin D could improve the clinical course of MS. The mechanisms underlying the effects of vitamin D in MS are not clear. Vitamin D3 increases the rate of differentiation of primary oligodendrocyte precursor cells (OPCs), suggesting that it might help remyelination in addition to modulating the immune response. Here we analyzed the transcriptome of differentiating rat CG4 OPCs treated with vitamin D2 or with D3 at 24 h and 72 h following onset of differentiation. Differentiation alone changed the expression of about 10% of the genes at 72 h compared to 24 h. Vitamin D2 and D3 exerted different effects on gene expression, with D3 influencing 1,272 genes and D2 574 at 24 h. The expression of the vast majority of these genes was either not changed in differentiating cells not exposed to vitamin D or followed the same trajectory as the latter. D3-repressed genes were enriched for gene ontology categories including transcription factors and the Notch pathway, while D3-induced genes were enriched for the Ras pathway. These findings should help to identify mechanisms mediating D3 action in MS.
Introduction
There is evidence that vitamin D deficiency is associated with increased risk of developing multiple sclerosis (MS) and with an increased rate of disease progression 1, 2 . However, the therapeutic efficacy of vitamin D supplementation in MS patients is still an open question, and interventional trials have reported inconclusive results 3 .
Vitamin D is produced in the skin by the action of ultraviolet light. After two successive hydroxylations, the 1,25(OH)D active form binds to the intracellular vitamin D receptor (VDR) and, in complex with the retinoid X receptor (RXR), regulates hundreds of genes through the vitamin D response element (VDRE) 1, 4 .
Vitamin D can also be assimilated from the diet or as a supplement. Both the plant/fungus-derived vitamin D2, ergocalciferol, and the animal-derived D3 form, cholecalciferol, are available as nutritional supplements; both can be hydroxylated into their active forms and bind VDR with similar affinity 5 , but there are differences in their catabolism and in their binding affinity to vitamin D binding protein (DBP), the major vitamin D transport protein in blood, with vitamin D2 binding DBP with lower affinity and being catabolised more quickly 1, 4 .
Studies comparing vitamin D2 and D3 for their ability to raise and maintain circulating levels of 25(OH)D, the serum marker of systemic vitamin D levels, have shown that vitamin D2 is less effective than D3 when given as single bolus 6 ; however, results following daily administration of D2 or D3 are controversial, with clinical trials showing higher efficacy of D3 7, 8 or equal efficacy 9 . In a recent metaanalysis, vitamin D2 and D3 were found equally effective in raising vitamin D levels in infants 10 . It has been suggested that vitamin D2 supplementation reduces circulating vitamin D3 levels; however, a recent randomized controlled trial showed that the reciprocal is also true 11 . The general consensus is that vitamin D3 is the preferred form to be administered 3 , but few studies have compared D2 and D3 in terms of their direct cellular effects under controlled conditions. The mechanisms mediating the protective action of vitamin D in MS are not fully characterized. In addition to regulating calcium homeostasis, vitamin D is immunomodulatory and anti-inflammatory 1, 2, 12 . In the last twenty years, many studies have reported effects on the brain; vitamin D inhibits neuro-inflammation, is neuroprotective and neurotrophic 1, [13] [14] [15] . VDR is present in neurons and glial cells 16, 17 .
Vitamin D acts directly on brain cells by promoting the differentiation of neural stem cells (NSCs) into neurons and oligodendrocytes (OLs), and inducing the expression of growth factors, such as nerve growth factor (NGF), in neurons and OLs 16, 18 .
The regenerative and neurotrophic effects of vitamin D, together with the presence of VDR in OLs, suggest that it might have a myelinating action, which might contribute to its protective effects in MS. In this respect, de la Fuente et al. found that vitamin D increased the differentiation and maturation of primary oligodendrocyte progenitor cells (OPCs) 19 .
Rat central glia-4 (CG4) OPCs are considered a good model of myelination in vitro;
the cells are maintained at the precursor stage by culture with growth factors (GFs), and can be differentiated into OLs by withdrawal of GFs and culture in differentiation medium (DM) [20] [21] [22] . Interestingly, Baas et al. found that CG4 cells express VDR, as primary OPCs, and respond to vitamin D by increasing expression of VDR and of NGF; however, an effect on myelin proteins was not found, leading to the conclusion that vitamin D does not positively affect the differentiation of these cells 16 .
To better understand the molecular mechanisms by which vitamin D acts on OLs, we analyzed the gene expression profile of rat CG4 OPCs in response to vitamin D, and compared vitamin D2 with D3.
Results
Set up and experimental treatment. We first established the appropriate experimental conditions for studying the effect of vitamin D on the gene expression profile of differentiating CG4 cells. In a previous study, Baas et al. found that VDR is present in CG4 OL precursors and its levels are increased 2-fold after culture for two days in differentiating conditions 16 ; we therefore hypothesized that a pre-incubation in differentiation medium (DM) for two days before treatment with vitamin D might increase the basal levels of VDR and the response to vitamin D. Since VDR is induced by vitamin D3 16 , we monitored basal and vitamin D3-induced VDR levels in different culture conditions. The dose of 100 nM vitamin D was chosen based on previous studies 16, 19 . Cells were plated, left to adhere overnight, then medium was changed to DM and cells were treated with vitamin D3 added at the same time as DM ( Fig. 1a) Therefore, the experimental design in Fig. 1b was used for the transcriptome analysis. After 48 h of pre-differentiation in DM, cells were treated with either vitamin D2 or D3; RNA was isolated following incubation for a further 24 h and 72 h and analyzed using whole genome DNA microarrays. The DNA microarray design uses unique oligonucleotide probes to quantify the abundance of gene transcripts containing the complementary sequences, and can include more than one probe per gene. In the presentation of the results below we make the distinction between probes and genes when necessary, and occasionally use the term "probes-genes" when no distinction is required.
Effect of vitamin D2 and D3 on gene expression profile.
Overall, addition of either vitamin D2 or D3 to differentiating cells significantly affected gene expression, an effect that was more marked at 72 h ( Fig. 2 ). Out of 15,247 probes, corresponding to 12,261 genes (ArrayExpress Accession number E-MTAB-8098) about 30% were affected by either vitamin D2 or D3 at 72 h, and 10% at 24 h ( Fig.   2a ).
The numbers of probes-genes affected by vitamin D2 and D3 were broadly similar at 72 h, with most differentially expressed genes regulated by both D2 and D3 ( Fig. 2a,   b ). However, the shorter-term response at 24 h showed a more pronounced response to vitamin D3, with notably larger numbers of probes-genes downregulated compared with vitamin D2 (721 versus 147 probes, corresponding to 664 versus 139 genes respectively; Fig. 2a ). At 24 h, most genes regulated by D2 were also regulated by D3, with some other genes regulated by D3 only (Fig. 2b ).
To visualize the global effect of vitamin D2 and D3 in relation to untreated cells, we performed a hierarchical cluster analysis of the 5,565 probes differentially regulated when comparing vitamin D2 or D3 with their respective controls at both time points, as well as untreated controls at 72 h versus 24 h. The results are shown as a heatmap in Fig. 2c .
By comparing untreated control cells (Ctrl) at 72 h with Ctrl at 24 h, we can see that differentiation alone noticeably affects gene expression. The actual number of probes-genes regulated in Ctrl 72 h versus Ctrl 24 h is reported in Fig. 2a . Figure 2c also shows that a number of genes with low expression in control cells are upregulated by both vitamin D2 and D3 at 24 h, an effect even more marked than that of differentiation at 72 h (e.g. cluster 5 in Fig. 2c ). Likewise, some of the genes that have a high expression in 24 h Ctrl cells seem to be down-regulated by vitamin D2 and D3 at 24 h, an effect similar to differentiation alone (e.g. cluster 9 in Fig. 2c ).
This trend is confirmed at 72 h, where vitamin D2 and D3 have a more marked effect than at 24 h.
Effect of differentiation.
To analyze the effect of vitamin D in relation to the effect of differentiation, we focused on the genes changed by culture in DM alone. As Ontology Biological Process (GO-BP) categories including "cell maturation" (p.adjust 7.77E-03), "axon ensheathment" (p.adjust 2.28E-03), "myelination" (p.adjust 6.75E-03); this is consistent with the fact that CG4 cells in DM differentiate over time 22, 23 . To visualize the effect of vitamin D2 and D3 at 24 h on the probes changed by differentiation alone (837 and 827 respectively, as mentioned above), we performed a hierarchical cluster analysis ( Fig. 3c ) of the expression abundance of these probes in untreated cells at 24 and 72 h (highlighting the effect of differentiation alone) and The clusters 1-4 in Fig. 3b comprise all the probes corresponding to the genes increased by differentiation alone. Both vitamins, and in particular vitamin D3, preferentially increase the expression of these genes at 24 h.
The same trend was confirmed for the down-regulated genes (clusters 5-8 in Fig.   3b ), where the preferential downregulating effect of vitamin D3 compared to D2 was vs Ctrl 24h). Differentially regulated genes were obtained according to the same criteria described in the legend to Fig. 2A . All the probes-genes are included in Supplementary File S1, where the membership of the pie chart groups is reported.
A similar analysis was performed at 72 h ( Fig. 4c and d ). At this time point, the overlap between vitamin D-and differentiation-regulated genes is smaller, and most of the effect on the gene expression profile is unique to vitamin D. a more marked effect on gene expression at 24 h than D2 ( Fig. 2a, Fig. 4a and b) , we analyzed the genes uniquely regulated by D3 (but not by D2) at 24 h and their behavior in relation to differentiation. As shown in Fig. 5 , all the genes uniquely regulated by vitamin D3 were either not changed by differentiation in absence of vitamin D, or followed the same trajectory as differentiation, with only five probes down-regulated by D3 but up-regulated by differentiation. (n=147, Fig. 2a and 4a) or D3 (n=721, Fig. 2a and 4b ) and of those uniquely downregulated by D3 (n=605; Fig. 5 ) indicated that the two forms of vitamin D produce notably different early effects on oligodendrocyte cells ( Supplementary Fig. S1 , Supplementary File S3). Interestingly, the 605 genes uniquely down-regulated by D3 at 24 h were significantly enriched for GO terms associated with transcription factor complex activity ("transcription factor complex", p. 
Discussion
The main finding of this study is that vitamin D2 and D3 exert markedly different effects on gene expression in differentiating OPCs. Although there is some overlap in the genes they regulate, D3 affects a larger repertoire of genes. In particular, we identified some genes that are specifically influenced by D2 only ( Vitamin D3 and D2 both up-regulated VDR expression, which was also up-regulated during OPC differentiation, in agreement with a previous report 16 . Both vitamins regulated the expression of many genes that were either not changed in differentiating cells not exposed to vitamin D or followed the same trajectory as the latter; only very few genes followed the opposite expression trajectory, suggesting that in this system, as in primary OLs 19 , vitamin D promotes rather than antagonizing differentiation.
Although at 72 h both vitamin D2 and D3 had similar effects on gene expression, at 24 h vitamin D3 was more potent, changing the expression of a substantially higher number of genes. The preferential action of D3 versus D2 was particularly evident when considering the down-regulated genes; only about one fourth of the genes down-regulated by D3 were also down-regulated by D2 at 24 h, whereas most of the genes down-regulated by D2 were also down-regulated by D3, as shown in Fig. 2 .
The higher efficacy of vitamin D3 compared to D2 in increasing myelination had been previously reported in a rat model of peripheral nerve injury 28 , but no studies had directly compared vitamin D2 and D3 in vitro on OL differentiation. It should be noted, however, that we did not observe any direct effect of vitamin D on the expression of myelin genes, in agreement with previous studies 16 , highlighting a limitation of this experimental model.
Functional enrichment analysis of the genes uniquely down-regulated by D3
(unchanged by D2) at 24 h highlighted an over-representation of transcription factors; among these, SRY-related HMG-Box Gene 4 (Sox4) and transcription factor EB (Tfeb), whose high expression has been previously associated with inhibition of myelination 29, 30 . In addition, the KEGG MAPK signaling pathway was overrepresented; of note, we previously reported that in this model inhibition of ERK1/2 MAPK increases OL differentiation 22 . Fibroblast growth factor receptor 2 (Fgfr2) and platelet derived growth factor A (Pdgfa) were included in this pathway (Supplementary File S3); since both Fgf and Pdgf are needed to maintain CG4
OPCs in the undifferentiated state 20, 22 , inhibition of Fgfr and Pdgf would promote differentiation.
Considering all the genes down-regulated by D3 at 24 h (and therefore possibly also by D2), enrichment of the Notch signaling pathway was identified. Activation of the Notch pathway inhibits OPC differentiation during development and is involved in the limited remyelination that characterizes MS 31, 32 . Notch is a transmembrane receptor that is activated upon binding to several ligands, including members of the Jagged and Delta-like families; these ligands induce sequential cleavage of Notch, with an essential cleavage performed by a gamma-secretase, which contains presenilin 33 .
The ligands Jagged 1 (Jag1) and delta-like canonical Notch ligand 3 (Dll3) were inhibited by both vitamin D2 and D3; in addition, presenilin 1 (Psen1) was inhibited only by vitamin D3. The inhibitory effect of vitamin D3 on gamma-secretase activity had been previously reported in the context of Alzheimer's disease 34 ; in this respect, gamma-secretase, in addition to Notch, also cleaves the amyloid precursor protein (APP) to produce amyloid-beta. Inhibition of Notch ligands and of Psn1, and of other genes belonging to the Notch pathway ( Supplementary File S3) , suggests a differentiating effect of vitamin D on these cells. In addition, preferential inhibition of Psn1 by vitamin D3 and not D2 indicates again that D3 is more efficacious than D2.
Interestingly, inhibition of Notch-signalling molecules, which play a role in cancer stem cell maintenance, is one of the mechanisms that mediate the anticancer properties of vitamin D 35, 36 .
Functional enrichment analysis of all the genes up-regulated by D3 revealed overrepresentation of the GO-BP Ras protein signal transduction ( Supplementary   Fig. S2, Supplementary File S3) . GTPases of the Ras family affect cell survival, proliferation and differentiation 37 , and among these Rras2 was recently found to be essential for OL differentiation 38 . Included in this pathway are also nerve growth factor (Ngf) and transforming growth factor beta 2 (Tgfb2), both reported to activate Ras-dependent signalling pathways and to promote OPC differentiation [39] [40] [41] [42] [43] . Vitamin D3-induced upregulation of Ngf in these cells was previously reported 16 . Of note, Rras2 and Ngf were also induced by D2, whereas Tgfb2 was uniquely induced by D3
( Supplementary File S3) . Also included in this pathway were several Rab genes, such as Rab36, Rab9d, Rab6a, and Rab3d. Rab proteins, involved in vesicular transport, are up-regulated during OL differentiation, in particular when OL start synthesizing myelin 44 ; interestingly Rab6a and Rab3d were uniquely up-regulated by D3 (GO Molecular Function (GO-MF) "GTP binding", Supplementary Fig. S2 ; Supplementary File S3 ). In addition, vitamin D3-induced transcription factors (GO Cellular Component (GO-CC) "nuclear transcription factor complex", Supplementary   Fig. S2 ) included Sox2, whose role in OL differentiation was recently reported 45, 46 and CCAAT/enhancer binding protein beta (Cebpb), a VDR-responsive gene that controls the differentiation of myeloid leukaemia cells 47 .
Our identification of specific vitamin D3-regulated genes in OPCs could provide important insights to understand the mechanisms mediating the activity of vitamin D in demyelinating disease and point to mechanisms additional to those associated with immune regulation, the latter being a major research focus for the action of vitamin D in the context of MS 1 .
Methods
Cell culture. The rat CG4 OL precursor cell line (OPC), originally obtained from primary cultures of bipotential oligodendrocyte-type-2-astrocytes (O-2A) 20 , was cultured as previously reported 22, 23 . CG4 cells are maintained at the precursor stage by culture in growth medium (GM), consisting of Dulbecco's modified Eagle medium (DMEM; Sigma-Aldrich) supplemented with biotin (10 ng/ml), bFGF (5 ng/ml), PDGF
(1 ng/ml), N1 supplement (all from Sigma-Aldrich) and 30% B104-conditioned medium, obtained as previously reported 23 Testing for differential expression between the experimental conditions was performed in LIMMA using linear modelling. Significance p-values were corrected for multiplicity using the Benjamini and Hochberg (BH) method, obtaining adjusted pvalues (adj.P.Val). All the 20,326 unique probes were subjected to differential expression analysis but only the data for the significantly differentially expressed probes mapping to an Entrez ID (5, 565) are reported in Supplementary File S1 and were considered in the downstream analyses. The list of the probes-genes is reported in Supplementary File S1.
